Gustave Roussy, Cancer Campus, Grand Paris

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling

Not Applicable

Conditions: Relapsed or Refractory Pediatric Tumor

Interventions: Procedure: biopsy or surgical resection of tumor and blood sampling

First Posted Date: 2015-11-25

Last Posted Date: 2020-02-17

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 700

Registration Number: NCT02613962

Locations: 🇫🇷
Gustave Roussy, Villejuif, Val De Marne, France
🇪🇸
Hospital Universitari Vall D'Hebron, Barcelona, Cataluna, Spain
🇮🇹
Fondazione IRCCS Istituto, Milano, Italy

and more 2 locations

Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Procedure: Biopsy
Procedure: Blood sample

First Posted Date: 2015-08-14

Last Posted Date: 2018-07-24

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 300

Registration Number: NCT02523612

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents

Not Applicable

Active, not recruiting

Conditions: Metastatic Oncogen-driven Cancer

Interventions: Procedure: Biopsy

First Posted Date: 2015-08-07

Last Posted Date: 2024-08-14

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 1500

Registration Number: NCT02517892

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies

Not Applicable

Conditions: Cancer

Interventions: Procedure: Biopsy

First Posted Date: 2015-08-07

Last Posted Date: 2019-01-03

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 700

Registration Number: NCT02517281

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers

Phase 1

Withdrawn

Conditions: Anaplastic Thyroid Cancers

Interventions: Drug: Adalimumab

First Posted Date: 2015-08-06

Last Posted Date: 2016-01-26

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Registration Number: NCT02516774

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France

Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Device: Functional magnetic resonance imaging
Device: Ultrasound

First Posted Date: 2015-08-06

Last Posted Date: 2016-02-10

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 10

Registration Number: NCT02516995

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France

Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors

Not Applicable

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Device: Transoral robotic-assisted surgery with Da Vinci Xi

First Posted Date: 2015-08-06

Last Posted Date: 2024-03-26

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 100

Registration Number: NCT02517125

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers

Phase 1

Completed

Conditions: Cervical Cancer

Interventions: Radiation: External radiotherapy + curietherapy
Drug: Vistide
Drug: Carboplatin

First Posted Date: 2015-08-05

Last Posted Date: 2016-06-09

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 15

Registration Number: NCT02515877

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val de Marne, France

Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: Oxaliplatin IV
Drug: Oxaliplatin HAI
Drug: LV5FU2
Drug: mFOLFOX6

First Posted Date: 2015-07-10

Last Posted Date: 2024-10-28

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 104

Registration Number: NCT02494973

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents

Not Applicable

Completed

Conditions: Non-Hodgkin Lymphoma

Interventions: Device: PET / CT

First Posted Date: 2015-07-02

Last Posted Date: 2019-06-18

Lead Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Target Recruit Count: 230

Registration Number: NCT02488369

Locations: 🇫🇷
Gustave Roussy Cancer Campus Grand Paris, Villejuif, Val De Marne, France

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy